A Prospective Evaluation Of The Radiographic Efficacy Of Etanercept In Patients With Rheumatoid Arthritis Or Psoriatic Arthritis

Trial Profile

A Prospective Evaluation Of The Radiographic Efficacy Of Etanercept In Patients With Rheumatoid Arthritis Or Psoriatic Arthritis

Completed
Phase of Trial: Phase IV

Latest Information Update: 29 Jun 2018

At a glance

  • Drugs Etanercept (Primary)
  • Indications Psoriatic arthritis; Rheumatoid arthritis
  • Focus Therapeutic Use
  • Acronyms PRERA
  • Sponsors Pfizer
  • Most Recent Events

    • 24 May 2018 Status changed from recruiting to completed.
    • 12 Dec 2017 Planned End Date changed from 1 Apr 2018 to 28 Apr 2018.
    • 12 Dec 2017 Planned primary completion date changed from 1 Apr 2018 to 28 Apr 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top